World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
10565
World Ranking
3274
National Ranking
1524

Sally A. Huber publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Sally A. Huber sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 181 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Sally A. Huber D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Sally A. Huber sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Sally A. Huber is affiliated with the University of Vermont in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a significant focus on Immunology, Epidemiology, Neurology, Cardiology and Cardiovascular Medicine, and Genetics. The main thematic areas cover Atherosclerosis and Cardiovascular Diseases, Adipokines, Inflammation, and Metabolic Diseases, Neuroinflammation and Neurodegeneration Mechanisms, Immune cells in cancer, IL-33, ST2, and ILC Pathways, Cardiac Fibrosis and Remodeling, and Immune Cell Function and Interaction.

Huber has contributed to multiple recent scholarly articles, including:

  • Innate and adaptive immune cell subsets as risk factors for coronary heart disease in two population-based cohorts (2020, Atherosclerosis)
  • Natural killer cells, gamma delta T cells and classical monocytes are associated with systolic blood pressure in the multi-ethnic study of atherosclerosis (MESA) (2021, BMC Cardiovascular Disorders)
  • Nonclassical Monocytes (CD14dimCD16+) Are Associated With Carotid Intima-Media Thickness Progression for Men but Not Women (2021, Arteriosclerosis Thrombosis and Vascular Biology)
  • Associations of Innate and Adaptive Immune Cell Subsets With Incident Type 2 Diabetes Risk: The MESA Study (2020, The Journal of Clinical Endocrinology & Metabolism)
  • Association of immune cell subsets with incident heart failure in two population-based cohorts (2022, ESC Heart Failure)

The frequent collaborators associated with Huber include:

  • Nels C. Olson
  • Margaret F. Doyle
  • Joseph A. Delaney
  • Bruce M. Psaty
  • Colleen M. Sitlani

Huber's work is often published in specialized venues, with recurrent contributions to:

  • Atherosclerosis
  • Leukemia
  • American Journal of Physiology-Heart and Circulatory Physiology
  • Circulation
  • Zeitschrift für Gastroenterologie

The research focuses on investigating immune cell subsets and their relationships to cardiovascular and metabolic diseases, including coronary heart disease, type 2 diabetes, and heart failure. Studies also include evaluation of cellular mechanisms related to blood pressure regulation and atherosclerosis progression.

Huber's scholarly output highlights interdisciplinary approaches at the intersection of immunology, cardiology, and metabolic health, with implications for understanding disease pathology and potential biomarkers within population-based cohorts.

Best Publications

  • Interleukin-6 Exacerbates Early Atherosclerosis in Mice

    S. A. Huber;P. Sakkinen;D. Conze;N. Hardin

  • Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens.

    S. A. Huber;P. A. Lodge

  • The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis.

    A Henke;S Huber;A Stelzner;J L Whitton

  • A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.

    K U Knowlton;E S Jeon;N Berkley;R Wessely

  • Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3.

    S A Huber;B Pfaeffle

  • T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia.

    Sally Ann Huber;P. Sakkinen;C. David;M. K. Newell

  • V gamma 1+ T cells suppress and V gamma 4+ T cells promote susceptibility to coxsackievirus B3-induced myocarditis in mice.

    S A Huber;D Graveline;M K Newell;W K Born

  • Reactive oxygen species induce virus-independent MAVS oligomerization in systemic lupus erythematosus.

    Iwona A. Buskiewicz;Theresa Montgomery;Elizabeth C. Yasewicz;Sally A. Huber

  • Different Potentials of γδ T Cell Subsets in Regulating Airway Responsiveness: Vγ1+ Cells, but Not Vγ4+ Cells, Promote Airway Hyperreactivity, Th2 Cytokines, and Airway Inflammation

    Youn-Soo Hahn;Christian Taube;Niyun Jin;Laura Sharp

  • Coxsackievirus-Induced Pancreatitis

    Sally Huber;Arlene I. Ramsingh

  • Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity.

    S A Huber;C J Gauntt;P Sakkinen

  • Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice.

    S. A. Huber;P. A. Lodge

  • Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms.

    P. A. Lodge;M. Herzum;J. Olszewski;S. A. Huber

  • Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes.

    S. A. Huber;L. P. Job;J. F. Woodruff

  • Coxsackievirus B3 Induces T Regulatory Cells, Which Inhibit Cardiomyopathy in Tumor Necrosis Factor-α Transgenic Mice

    Sally A. Huber;Arthur M. Feldman;Danielle Sartini

  • The Y chromosome as a regulatory element shaping immune cell transcriptomes and susceptibility to autoimmune disease

    Laure K. Case;Emma H. Wall;Julie A. Dragon;Naresha Saligrama

  • Vgamma4(+) T cells promote autoimmune CD8(+) cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice: role for CD4(+) Th1 cells.

    S. A. Huber;D. Sartini;M. Exley

  • Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsakieviral myocarditis.

    S A Huber;M W Cunningham

  • Local production of IFN-gamma by invariant NKT cells modulates acute Lyme carditis.

    Chris M. Olson;Tonya C. Bates;Hooman Izadi;Justin D. Radolf

  • Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2.

    S A Huber;J Polgar;P Schultheiss;P Schwimmbeck

  • Depletion of a gamma delta T cell subset can increase host resistance to a bacterial infection.

    Rebecca L. O’Brien;Xiang Yin;Sally A. Huber;Koichi Ikuta

Frequent Co-Authors

Bruce M. Psaty
Bruce M. Psaty University of Washington
Russell P. Tracy
Russell P. Tracy University of Vermont
Rebecca L. O'Brien
Rebecca L. O'Brien National Jewish Health
Alan L. Landay
Alan L. Landay The University of Texas Medical Branch at Galveston
David Lyden
David Lyden Cornell University
Ralph C. Budd
Ralph C. Budd University of Vermont
Willi K. Born
Willi K. Born University of Colorado Anschutz Medical Campus
Richard A. Kronmal
Richard A. Kronmal University of Washington
Mark A. Exley
Mark A. Exley Brigham and Women's Hospital
Nancy S. Jenny
Nancy S. Jenny University of Vermont

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing a career in immunology, understanding the diverse educational routes in healthcare is essential. Many professionals start with foundational degrees such as a Bachelor of Science in Nursing (BSN). Non-nurses seeking to enter this field can consider the best online BSN programs for non nurses, which offer flexible pathways to gain essential nursing knowledge.

Accelerated pathways like the ABSN programs with high acceptance rates make it easier for career changers to quickly enter nursing. For those aiming to become nurse practitioners with a focus on family health, the accelerated FNP program provides an intensive option to fast-track expertise.

Specializing further, nurses can pursue acute care NP certification to work in critical care settings. These certifications expand career opportunities and deepen clinical knowledge, which can be highly relevant in immunology-related cases.

Exploring these degrees and certifications can provide a strong foundation for meaningful work in immunology, blending clinical practice with advanced scientific understanding.

Best Scientists Citing Sally A. Huber

Trending Scientists

Recently Published Articles